BOCT Inhibitors

The chemical class of SLC22A17 Inhibitors encompasses compounds that potentially modulate the function of SLC22A17 by influencing related transport mechanisms and cellular pathways. These inhibitors do not directly target SLC22A17 but affect the cellular environment and mechanisms in which SLC22A17 operates.

Compounds such as Probenecid, Cimetidine, and Quinidine are known to inhibit various transporters and could potentially impact SLC22A17's transport function. Verapamil, a calcium channel blocker, and Omeprazole, a proton pump inhibitor, might also influence ion transport processes related to SLC22A17. Other inhibitors, including Ranitidine, Furosemide, Losartan, Ketoconazole, Chlorpromazine, Nicotine, and Amiloride, affect various aspects of cellular transport and signaling pathways. These compounds could indirectly modulate SLC22A17's activity through their impact on related transport mechanisms and cellular processes.